BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 20127549)

  • 21. International Drug Discovery Science and Technology--BIT's Seventh Annual Congress.
    Bodovitz S
    IDrugs; 2010 Jan; 13(1):23-5. PubMed ID: 20024843
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bendamustine for the treatment of chronic lymphocytic leukemia and rituximab-refractory, indolent B-cell non-Hodgkin lymphoma.
    Dennie TW; Kolesar JM
    Clin Ther; 2009; 31 Pt 2():2290-311. PubMed ID: 20110042
    [TBL] [Abstract][Full Text] [Related]  

  • 23. American Society of Hematology--50th Annual Meeting and Exposition--Part 1.
    Scattereggia J; Millar E
    IDrugs; 2009 Feb; 12(2):63-5. PubMed ID: 19216123
    [No Abstract]   [Full Text] [Related]  

  • 24. Identification of a novel 14-3-3zeta binding site within the cytoplasmic domain of platelet glycoprotein Ibalpha that plays a key role in regulating the von Willebrand factor binding function of glycoprotein Ib-IX.
    Yuan Y; Zhang W; Yan R; Liao Y; Zhao L; Ruan C; Du X; Dai K
    Circ Res; 2009 Dec; 105(12):1177-85. PubMed ID: 19875727
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High shear stress attenuates agonist-induced, glycoprotein IIb/IIIa-mediated platelet aggregation when von Willebrand factor binding to glycoprotein Ib/IX is blocked.
    Iijima K; Murata M; Nakamura K; Kitaguchi T; Handa M; Watanabe K; Fujimura Y; Yoshioka A; Ikeda Y
    Biochem Biophys Res Commun; 1997 Apr; 233(3):796-800. PubMed ID: 9168936
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Terrapinn's world influenza congress Europe 2009. Part 2.
    Veryard C
    IDrugs; 2010 Feb; 13(2):78-9. PubMed ID: 20127556
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The 50th Annual Meeting of the American Society of Hematology.
    Cunningham S; Muneer S
    Clin Lymphoma Myeloma; 2009 Jun; 9(3):197-205. PubMed ID: 19525188
    [No Abstract]   [Full Text] [Related]  

  • 28. The American Society for Virology--29th Annual Meeting.
    Minieri Arroyo J
    IDrugs; 2010 Sep; 13(9):615-8. PubMed ID: 20799142
    [TBL] [Abstract][Full Text] [Related]  

  • 29. American Association for Cancer Research--100th Annual Meeting. New therapeutic developments: part 2. 18-22 April 2009, Denver, CO, USA.
    Gale S; McGee V; Lee W
    IDrugs; 2009 Jun; 12(6):335-8. PubMed ID: 19517309
    [No Abstract]   [Full Text] [Related]  

  • 30. American Association for Cancer Research--100th Annual Meeting. New therapeutic developments: part 1. 18-22 April 2009, Denver, CO, USA.
    Gale S; McGee V; Lee W
    IDrugs; 2009 Jun; 12(6):331-4. PubMed ID: 19517308
    [No Abstract]   [Full Text] [Related]  

  • 31. Developments in the treatment of lymphoproliferative disorders: rising to the new challenges of CLL therapy. A report of a symposium presented during the 48th American Society of Hematology Annual Meeting and Exposition, December 8, 2006, Orlando, Florida.
    Clin Adv Hematol Oncol; 2007 Mar; 5(3 Suppl 5):1-14; quiz 15-6. PubMed ID: 17519887
    [No Abstract]   [Full Text] [Related]  

  • 32. American Academy of Allergy, Asthma and Immunology (AAAAI)-2010 annual meeting. 26 February-2 March 2010, New Orleans, LA, USA.
    Bielory L
    IDrugs; 2010 May; 13(5):304-7. PubMed ID: 20432184
    [TBL] [Abstract][Full Text] [Related]  

  • 33. American Society of Clinical Oncology--46th annual meeting.
    Al-Shamahi A; Murch L; Kirkham K
    IDrugs; 2010 Aug; 13(8):506-9. PubMed ID: 20721815
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biomarkers in Clinical Trials--SMi Conference. 23-24 September 2009, London, UK.
    Walker G
    IDrugs; 2009 Nov; 12(11):673-4. PubMed ID: 19844848
    [TBL] [Abstract][Full Text] [Related]  

  • 35. American Society of Gene & Cell Therapy--13th Annual Meeting.
    Romano G
    IDrugs; 2010 Jul; 13(7):444-7. PubMed ID: 20582867
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Coronary Artery Disease - Eighth International Congress. From prevention to intervention.
    Wong NC
    IDrugs; 2009 Dec; 12(12):742-6. PubMed ID: 19943213
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of natural products in drug discovery and development in the new millennium.
    Harvey A
    IDrugs; 2010 Feb; 13(2):70-2. PubMed ID: 20127553
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A second report of platelet-type von Willebrand disease with a Gly233Ser mutation in the GPIBA gene.
    Nurden P; Lanza F; Bonnafous-Faurie C; Nurden A
    Thromb Haemost; 2007 Feb; 97(2):319-21. PubMed ID: 17264965
    [No Abstract]   [Full Text] [Related]  

  • 39. [Involvement of platelet collagen receptors in primary hemostasis].
    Kralisz U; Stasiak M
    Postepy Biochem; 2007; 53(4):344-55. PubMed ID: 19024899
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A role for von Willebrand factor in Streptococcus sanguis-induced platelet activation.
    McNicol A; Eyer E; Jackson EC; Israels SJ
    Thromb Haemost; 2007 Dec; 98(6):1382-4. PubMed ID: 18064343
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.